Search PubMed⌕ Search

Biomedical subjects

H Walach

Publications and source records attributed to H Walach.

At least 19 recordsLinked to original sources

A systematic review of the quality of homeopathic pathogenetic trials published from 1945 to 1995.

BACKGROUND: The quality of information gathered from homeopathic pathogenetic trials (HPTs), also known as 'provings', is fundamental to homeopathy. We systematically reviewed HPTs published in six languages (English, German, Spanish, French, Portuguese and Dutch) from 1945 to 1995, to assess their quality in terms of the validity of the information they provide. METHODS: The literature was comprehensively searched, only published reports of HPTs were included. Information was extracted by two reviewers per trial using a form with 87 items. Information on: medicines, volunteers, ethical aspects, blinding, randomization, use of placebo, adverse effects, assessments, presentation of data and number of claimed findings were recorded. Methodological quality was assessed by an index including indicators of internal and external validity, personal judgement and comments of reviewers for each study. RESULTS: 156 HPTs on 143 medicines, involving 2815 volunteers, produced 20,538 pathogenetic effects (median 6.5 per volunteer). There was wide variation in methods and results. Sample size (median 15, range 1-103) and trial duration (mean 34 days) were very variable. Most studies had design flaws, particularly absence of proper randomization, blinding, placebo control and criteria for analysis of outcomes. Mean methodological score was 5.6 (range 4-16). More symptoms were reported from HPTs of poor quality than from better ones. In 56% of trials volunteers took placebo. Pathogenetic effects were claimed in 98% of publications. On average about 84% of volunteers receiving active treatment developed symptoms. The quality of reports was in general poor, and much important information was not available. CONCLUSIONS: The HPTs were generally of low methodological quality. There is a high incidence of pathogenetic effects in publications and volunteers but this could be attributable to design flaws. Homeopathic medicines, tested in HPTs, appear safe. The central question of whether homeopathic medicines in high dilutions can provoke effects in healthy volunteers has not yet been definitively answered, because of methodological weaknesses of the reports. Improvement of the method and reporting of results of HPTs are required. REFERENCES: References to all included RCTs are available on-line at.

Homeopathy↗

Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT.

When homeopathy is tested in clinical trials, understanding and appraisal is likely to be improved if published reports contain details of prescribing strategies and treatments. An international Delphi panel was convened to develop consensus guidelines for reporting homeopathic methods and treatments. The panel agreed 28 treatment- and provider-specific items that supplement the Consolidated Standards of Reporting Trials (CONSORT) Statement items 2, 3, 4 and 19. The authors recommend these for adoption by authors and journals when reporting trials of homeopathy.

Consensus↗

[Procedures of complementary medicine. Spiritual healing and healing through prayer: a discussion paper].

Spiritual healing and healing through prayer have been among the methods for healing diseases of mankind since time immemorial. Even today they are quite popular in many parts of the Western world, as epidemiological data testify. Also in Germany, although less systematic data are available, spiritual healing is being used quite a lot. This interest is driven mainly by word of mouth and media presentation of spectacular single case descriptions of healing. Scientifically speaking, such cases present a challenge to science to understand the mechanisms at work. Systematic scientific studies, however, are rather sporadic and sometimes amateur-like efforts. However, the data available show two general results: patients seeking out healing normally profit to a clinically significant degree. At the same time, there is little evidence that these effects are specific in nature. It could be the case that the mechanisms at work--if there are any specific mechanisms at all--do not follow the normal expected causal routes of activity, and hence the methodology applied might be misguided or incapable of capturing the effects. If there are generalised non-local effects at work, a hypothesis worth testing, then this has profound consequences both for research and for the interpretation of results.

Biomedical Research↗

Entangled--and tied in knots! Practical consequences of an entanglement model for homeopathic research and practice.

The assertion that 'local' theories of homeopathy are traditional appears to be contradicted by Hahnemann's description of the action of homeopathic medicines as 'spirit-like'. Entanglement theory prohibits the use of entangled states to convey information. Experimental proof of entanglement can only come indirectly. The implications for clinical research include that positive results will probably be found only in large series and that studies should avoid imposing a causal framework.

Controlled Clinical Trials as Topic↗

[Amalgam risk assessment with coverage of references up to 2005].

Amalgam, which has been in use in dentistry for 150 years, consists of 50 % elemental mercury and a mixture of silver, tin, copper and zinc. Minute amounts of mercury vapour are released continuously from amalgam. Amalgam contributes substantially to human mercury load. Mercury accumulates in some organs, particularly in the brain, where it can bind to protein more tightly than other heavy metals (e. g. lead, cadmium). Therefore, the elimination half time is assumed to be up to 1 - 18 years in the brain and bones. Mercury is assumed to be one of the most toxic non-radioactive elements. There are pointers to show that mercury vapour is more neurotoxic than methyl-mercury in fish. Review of recent literature suggests that mercury from dental amalgam may lead to nephrotoxicity, neurobehavioural changes, autoimmunity, oxidative stress, autism, skin and mucosa alterations or non-specific symptoms and complaints. The development of Alzheimer's disease or multiple sclerosis has also been linked to low-dose mercury exposure. There may be individual genetical or acquired susceptibilities for negative effects from dental amalgam. Mercury levels in the blood, urine or other biomarkers do not reflect the mercury load in critical organs. Some studies regarding dental amalgam reveal substantial methodical flaws. Removal of dental amalgam leads to permanent improvement of various chronic complaints in a relevant number of patients in various trials. Summing up, available data suggests that dental amalgam is an unsuitable material for medical, occupational and ecological reasons.

Adult↗

Homeopathic proving symptoms: result of a local, non-local, or placebo process? A blinded, placebo-controlled pilot study.

BACKGROUND: Homeopathic pathogenetic trials (HPTs) (provings) are the pillar of homeopathy. Symptoms experienced by healthy volunteers are used to find the correct medicine for therapy. It is unclear whether these symptoms are specific or due to placebo noise. Furthermore, it is uncertain whether proving effects, if present at all, are due to a local or non-local process OBJECTIVES: To develop a test model which allows for testing if homeopathic proving symptoms are caused by placebo or causative mechanisms, and if these symptoms are due to local or non-local processes. DESIGN: Randomised, blinded, placebo-controlled, parallel-group study, with 1-week baseline and 2-weeks proving period. SUBJECTS: 11 healthy volunteers from two different homeopathic schools. PROVING SUBSTANCE: An homeopathic medicine (Cantharis 30c), blindly chosen from 12 potential medicines, compared to placebo. OUTCOME MEASURE: Number of symptoms typical for the medicine in the experimental and control group during baseline and proving period. RESULTS: During baseline there was no difference in the number of typical or atypical symptoms in either group. During the proving period, both more typical symptoms for Cantharis (P= 0.03) and more atypical symptoms (P= 0.02) were observed compared to baseline. Between-group differences were not significant. Effect sizes for the difference between the proving and control group for typical symptoms was d=0.4, and for atypical symptoms d=0.6. DISCUSSION: This proving model could be valuable in studying the validity of proving symptoms of homeopathic substances in healthy volunteers. CONCLUSION: Homeopathic proving symptoms appear to be specific to the medicine and do not seem to be due to a local process. Since this was a pilot study using a small number of provers, rival hypotheses cannot be ruled out and the study needs replication.

Adult↗

Amalgam studies: disregarding basic principles of mercury toxicity.

Dental amalgam, which has been used for over 150 years in dental practice, consists of about 50% metallic mercury. Studies on animal and humans show that mercury is continuously released from dental amalgam and absorbed by several body tissues. It is widely accepted that the main source of mercury vapor is dental amalgam and it contributes substantially to mercury load in human body tissues. There is still a controversy about the consequences of this additional mercury exposure from amalgam to human health. Many studies were performed to evaluate possible adverse effects. In this comment, these studies were analyzed with regard to their methodical quality by considering the newest findings on mercury toxicity and metabolism. In sum, a number of studies are methodically flawed drawing inaccurate conclusions as to the safety of dental amalgam.

Dental Amalgam↗

A double-blind, randomized, homeopathic pathogenetic trial with healthy persons: comparing two high potencies.

BACKGROUND AND OBJECTIVE: According to homeopathic theory, symptoms provoked by the homeopathic remedy in a pathogenetic trial (PT) make up the remedy picture serving as the basis for the homeopathic treatment. Little is known whether the symptoms produced by the remedy differ from symptoms produced by placebo. This is because both homeopathic remedy and placebo also produce so-called unspecific effects due to psychological reasons. We therefore explore the distinctiveness of homeopathic symptoms and placebo symptoms. DESIGN: A three-armed, randomized PT pilot study. SETTING: A blinded materia medica expert identifies symptoms with regard to their number and specificity. PARTICIPANTS: 21 healthy homeopathic practitioners note symptoms produced after remedy intake. INTERVENTIONS: Patients are randomly assigned to receive either (1) Calendula officinalis, (2) Ferrum muriaticum, or (3) placebo. After a seven-day baseline symptoms recording period, proving substances are taken until symptoms occur. In daily supervision phone calls, symptoms are verified by the supervisor. MAIN OUTCOME MEASURE: Total number of symptoms produced and number of specific symptoms produced. OUTLOOK: The results showed that both remedies 'produced' significantly more symptoms than placebo. With regard to the specificity, the Calendula officinalis group displayed more remedy-specific symptoms than placebo. However, in the Ferrum muriaticum group more Calendula symptoms than placebo were also recorded.

Adult↗

Entanglement model of homeopathy as an example of generalized entanglement predicted by weak quantum theory.

Homeopathy is scientifically banned, both for lack of consistent empirical findings, but more so for lack of a sound theoretical model to explain its purported effects. This paper makes an attempt to introduce an explanatory idea based on a generalized version of quantum mechanics (QM), the weak quantum theory (WQT). WQT uses the algebraic formalism of QM proper, but drops some restrictions and definitions typical for QM. This results in a general axiomatic framework similar to QM, but more generalized and applicable to all possible systems. Most notably, WQT predicts entanglement, which in QM is known as Einstein-Podolsky-Rosen (EPR) correlatedness within quantum systems. According to WQT, this entanglement is not only tied to quantum systems, but is to be expected whenever a global and a local variable describing a system are complementary. This idea is used here to reconstruct homeopathy as an exemplification of generalized entanglement as predicted by WQT. It transpires that homeopathy uses two instances of generalized entanglement: one between the remedy and the original substance (potentiation principle) and one between the individual symptoms of a patient and the general symptoms of a remedy picture (similarity principle). By bringing these two elements together, double entanglement ensues, which is reminiscent of cryptographic and teleportation applications of entanglement in QM proper. Homeopathy could be a macroscopic analogue to quantum teleportation. This model is exemplified and some predictions are derived, which make it possible to test the model.

Evidence-Based Medicine↗

[Does weather modify headaches? An empirical evaluation of bio-weather categorization].

BACKGROUND: Headache patients frequently refer to the weather as a triggering factor for their headaches. Apart from a literature review, we tested empirically the generally used classification of weather epochs into a so called bio-weather categorization. METHOD: Headache diary data (frequency, duration, intensity) of 98 patients in a headache trial were correlated with the concurrent bio-weather classification. RESULTS: Correlations were small and significant only for the summer-half of the year (contingency coefficients between 0.04 and 0.06). The classification of certain types of weather as headache prone as used in the current bio-weather classification could only partly be verified. CONCLUSION: There is a clear but small correlation between headache and weather. More, and more fine-grained, studies are warranted, especially for identifying those patients at risk for weather prone headaches. Clinically more important is the weather as a source of causal attributions.

Data Interpretation, Statistical↗

[Distant healing and diabetes mellitus. A pilot study].

BACKGROUND: The Institut für Grenzgebiete der Psychologie und Psychohygiene, Freiburg (IGPP) in cooperation with the Abteilung Naturheilkunde, University Hospital, Zürich investigated whether Distant Healing has a beneficial effect on patients with diabetes mellitus regarding the state of the disease and quality of life. OBJECTIVE: The goal of the pilot study was to observe the progression of the disease with various medical and psychological measures and to explore which of them might be sensitive for measuring possible treatment effects. PATIENTS AND METHODS: 14 diabetic patients were observed for a period of 16 weeks. Within this time they underwent a treatment of 4 consecutive weeks (weeks 9-12) by 5 experienced and trustworthy healers each. Patients were informed about the duration of the treatment but not about the time point of its beginning. Patients and healers never met and there was no contact between researchers and patients during the study period. RESULTS: With regard to medical parameters, reduction in fructosamine level was observed during the healing period, increasing fructosamine level after the end of the healing period. Sensitivity, measured only at the beginning and at the end of the study period, decreased significantly. The other parameters showed some significant changes but there was no correlation to the Distant Healing intervention. Regarding the psychological data, only improvements were observed. CONCLUSIONS: The results indicate the possibility that a Distant Healing intervention could have certain effects on patients with diabetes mellitus.

Adult↗

Efficacy of distant healing--a proposal for a four-armed randomized study (EUHEALS).

BACKGROUND: Distant healing as a treatment modality is frequently used by patients and healers. Some preliminary evidence suggests possible effects. Since patients suffering from multiple chemical sensitivity and chronic fatigue syndrome have only few effective treatment options, distant healing will be offered as a treatment within a formal trial of distant healing. DESIGN AND METHOD: A four-armed randomized trial will include 400 patients with self-attributed, environmental problems who fulfil the diagnostic criteria of severe idiopathic chronic fatigue, chronic fatigue syndrome or multiple chemical sensitivity. Patients will be recruited by specialized general practitioners and environmental clinics. They will be treated by healers distributed all over Europe, coming from various healing traditions and nationalities. Each patient will be treated by 3 healers. Healers will have no contact with the patients and will only be provided with the patient's Christian name and a photograph. The patients will be randomized to one of 4 groups in a 2 x 2 factorial design. They will either receive (distant) healing or not, and either know or not know this decision. Thereby the effects of expectation and of time can be disentangled from the specific effects of healing. OUTCOME MEASURE: Primary outcome measure will be the mental health summary scale of the MOS SF-36. The measure will be taken at the beginning and at the end of a 6- month treating or waiting period, respectively. A variety of moderator variables will be considered to evaluate which of these may be predictive of outcome.

Fatigue Syndrome, Chronic↗